Yahoo Buys Tumblr f...
Health Care: Drugs
pSivida Ltd. (PSDV: NASDAQ)
$2.97 -0.03 | -1.03%
05/21/13 - 12:54 PM ET
Company Balance Sheet
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 4.62M | 12.91M | 15.51M | 6.90M |
| Receivables | 967.00K | 843.00K | 1.11M | 815.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 15.96M | 25.37M | 19.03M | 8.13M |
| Property, Plant & Equipment, Gross | 2.26M | 3.95M | 3.66M | 3.93M |
| Accumulated Depreciation & Depletion | 1.92M | 3.83M | 3.62M | 3.86M |
| Property, Plant & Equipment, Net | 335.00K | 123.00K | 43.00K | 66.00K |
| Intangibles | 4.23M | 21.56M | 23.88M | 28.80M |
| Other Non-Current Assets | 77.00K | 60.00K | 60.00K | 109.00K |
| Total Non-Current Assets | 4.64M | 21.75M | 23.98M | 28.98M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 20.60M | 47.11M | 43.01M | 37.10M |
| Accounts Payable | 394.00K | 328.00K | 387.00K | 284.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 170.00K | 1.31M | 971.00K |
| Total Current Liabilities | 3.18M | 5.03M | 2.93M | 8.72M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 13.00K | 222.00K | 222.00K |
| Other Non-Current Liabilities | 3.78M | 4.64M | 6.82M | 4.62M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 3.78M | 4.65M | 7.04M | 4.84M |
| Total Liabilities | 6.96M | 9.68M | 9.97M | 13.56M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 13.64M | 37.43M | 33.04M | 23.54M |
| Common Par | 21.00K | 21.00K | 19.00K | 18.00K |
| Additional Paid In Capital | 264.43M | 262.91M | 250.80M | 248.50M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -251.76M | -226.92M | -218.30M | -227.05M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 942.00K | 1.43M | 521.00K | 2.07M |
| Total Capitalization | 13.64M | 37.43M | 33.04M | 23.54M |
| Total Equity | 13.64M | 37.43M | 33.04M | 23.54M |
| Total Liabilities & Stock Equity | 20.60M | 47.11M | 43.01M | 37.10M |
| Total Common Shares Outstanding | 20.80M | 20.75M | 18.53M | 18.29M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 20.79M | 19.49M | 18.40M | 18.26M |
| Diluted Weighted Shares Outstanding | 20.79M | 19.49M | 18.90M | 18.26M |
| Number of Employees | 29 | 26 | 23 | 22 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with PSDV
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- Userdisaster
Latest PSDV Headlines from TheStreet
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- 4 Stocks Under $10 Making Big Moves 07.24.12 | 02:07 pm
- 5 Stocks Poised for Breakouts 06.29.12 | 12:06 pm
- 5 Stocks Setting Up to Break Out 04.25.12 | 11:04 am
- 8 Stocks Under $10 Moving Higher 03.27.12 | 02:03 pm
- 5 Stocks Under $5 Making Big Moves 02.24.12 | 02:02 pm
- Biotech Calendar: Key Dates for November 11.01.11 | 10:11 am
- pSivida - Upgrades & Downgrades 09.24.10 | 01:09 pm
- Biotech Stocks Under $5
12.23.09 | 05:12 pm - Chromcraft, pSivida: Midday Volume Plays 11.18.09 | 01:11 pm
Press Releases for PSDV
- PSivida Reports Updates On ILUVIEN® For Planned Resubmission To FDA And European Launch - Business Wire 03.22.13 | 08:03 am
- PSivida VP Of Research To Discuss Company’s Protein And Antibody Sustained Delivery System At 5th Ocular Diseases And Drug Development Conference - Business Wire 03.20.13 | 01:03 pm
- PSivida Corp. Reports Second Quarter Fiscal Year 2013 Results - Business Wire 02.06.13 | 04:02 pm
- PSivida CEO To Present At 15th Annual BioCEO & Investor Conference February 12 - Business Wire 02.04.13 | 11:02 am
- PSivida Corp. Announces Second Quarter 2013 Financial Results Release Date And Conference Call Information - Business Wire 01.30.13 | 04:01 pm
- Psivida Corp. Announces Final Published Guidance From U.K.’s Nice And Pursuit Of Patient Access Scheme For Iluvien® For DME - Business Wire 01.23.13 | 07:01 am
- PSivida Corp. Announces Spain Grants ILUVIEN® Marketing Approval For Chronic Diabetic Macular Edema - Business Wire 01.17.13 | 07:01 am
- PSivida Corp. Reports Patient Access Scheme Being Developed By Alimera To Address Cost Concerns Following Negative Final Draft Guidance By U.K.’s NICE For ILUVIEN® For DME - Business Wire 11.29.12 | 07:11 pm
- PSivida Corp. Reports First Quarter Fiscal Year 2013 Results - Business Wire 11.08.12 | 04:11 pm
- PSivida Corp Announces First Quarter 2013 Financial Results Release Date And Conference Call Information - Business Wire 11.01.12 | 04:11 pm
Partner Headlines for PSDV
- Benzinga's Microcap Movers for Friday July 27, 2012 - Benzinga 07.29.12 | 09:07 am
- Healthcare Business Review: pSivida's CURES Blindness, Baxter's DUTCH Deal - Wall St. Cheat Sheet 07.20.12 | 09:07 am
- Psivida Licensee Set For European Launch By Year's End - Seeking Alpha 04.11.12 | 09:04 am
- Benzinga's Microcap Movers for Friday February 24, 2012 - Benzinga 02.26.12 | 04:02 pm
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 19 High Growth Micro Cap Stocks Under $10 - Seeking Alpha 01.23.11 | 07:01 am
- Alimera Gets Unwelcome Christmas Message From FDA - Seeking Alpha 12.26.10 | 01:12 am
